Add Company
Join Now

ProKidney Corp. Revenue and Competitors

License our Company Data API

Winston-Salem, NC USA

Location

#7027

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • ProKidney Corp.'s estimated annual revenue is currently $47M per year.(i)
  • ProKidney Corp.'s estimated revenue per employee is $189,375

Employee Data

  • ProKidney Corp. has 248 Employees.(i)
  • ProKidney Corp. grew their employee count by 34% last year.

ProKidney Corp.'s People

NameTitleEmail/Phone
1
Chief People OfficerReveal Email/Phone
2
Chief Legal Officer and Corporate SecretaryReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Regulatory OfficerReveal Email/Phone
5
SVP Global Clinical OperationsReveal Email/Phone
6
VP Program Leadership & ManagementReveal Email/Phone
7
EVP, Technical OperationsReveal Email/Phone
8
SVP, Global Clinical OperationsReveal Email/Phone
9
Head Environment, Health, and SafetyReveal Email/Phone
10
EVP, Clinical Development and CommercializationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.9M777%N/AN/A
#2
$6221.7M40140-4%N/AN/A
#3
$2M130%N/AN/A
#4
$0.8M5-55%N/AN/A
#5
$2.8M186%$11.1MN/A
#6
$1M13-41%N/AN/A
#7
$1.7M110%N/AN/A
#8
$0.6M40%N/AN/A
#9
$5.9M38-5%N/AN/A
#10
$6.8M447%N/AN/A
Add Company

What Is ProKidney Corp.?

ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.

keywords:N/A

N/A

Total Funding

248

Number of Employees

$47M

Revenue (est)

34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$66M2605%N/A
#2
$29.2M2600%N/A
#3
$92.5M2624%N/A
#4
$38.6M27620%N/A
#5
$69.8M2780%$35M